All Stories

  1. Bringing androgens up a NOTCH in breast cancer
  2. Mouse GDF9 decreases KITL gene expression in human granulosa cells
  3. Complexities of androgen receptor signalling in breast cancer
  4. Identification of Androgen Receptor Splice Variant Transcripts in Breast Cancer Cell Lines and Human Tissues
  5. Antiandrogenic actions of medroxyprogesterone acetate on epithelial cells within normal human breast tissues cultured ex vivo
  6. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype
  7. SGTA: A New Player in the Molecular Co-Chaperone Game
  8. Small glutamine-rich tetratricopeptide repeat–containing protein alpha is present in human ovaries but may not be differentially expressed in relation to polycystic ovary syndrome
  9. Androgen Receptor Protein Levels Are Significantly Reduced in Serous Ovarian Carcinomas Compared with Benign or Borderline Disease but Are Not altered by Cancer Stage or Metastatic Progression
  10. Minireview: The Androgen Receptor in Breast Tissues: Growth Inhibitor, Tumor Suppressor, Oncogene?
  11. An androgen receptor mutation in the MDA-MB-453 cell line model of molecular apocrine breast cancer compromises receptor activity
  12. Multiple nuclear receptor signaling pathways mediate the actions of synthetic progestins in target cells
  13. Abstract 274: The combined actions of DHT and MPA lead to altered AR signaling in normal and malignant post-menopausal breast epithelial cells
  14. Therapeutic response to CDK4/6 inhibition in breast cancer defined by ex vivo analyses of human tumors
  15. FOXA1: master of steroid receptor function in cancer
  16. PCOS Forum: research in polycystic ovary syndrome today and tomorrow
  17. Polycystic ovary syndrome: steroid assessment for diagnosis
  18. Abstract 5367: Medroxyprogesterone acetate impedes 5α-dihydrotesterone induced androgen receptor signaling in normal and malignant human breast epithelial cells
  19. Evaluation of Testosterone Supplementation during Anastrozole Therapy in a Breast Explant Model.
  20. Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries
  21. 415. Increased expression of an androgen receptor regulated gene, kit ligand, in polycystic ovaries
  22. 6A-2 Genetic/epigenetic and environmental origins of pcos
  23. Polycystic ovary syndrome
  24. Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer
  25. Epigenetic Modification of the X Chromosome Influences Susceptibility to Polycystic Ovary Syndrome
  26. 270. Androgens augment the mitogenic effects of oocyte-secreted factors and growth differentiation factor 9 on porcine granulosa cells
  27. Interactions Between Androgen and Growth Factors in Granulosa Cell Subtypes of Porcine Antral Follicles
  28. Polycystic ovary syndrome—diagnosis and etiology
  29. The Androgen Receptor CAG Repeat Polymorphism and X-Chromosome Inactivation in Australian Caucasian Women with Infertility Related to Polycystic Ovary Syndrome
  30. The Androgen Receptor CAG Repeat Polymorphism and X-Chromosome Inactivation in Australian Caucasian Women with Infertility Related to Polycystic Ovary Syndrome
  31. Polycystic Ovary Syndrome
  32. Androgens induce divergent proliferative responses in human breast cancer cell lines
  33. MDA-MB-453, an androgen-responsive human breast carcinoma cell line with high level androgen receptor expression
  34. Retinoic acid enhances the displacement of newly synthesized hyaluronate from cell layer to culture medium during early phases of chondrogenesis
  35. Androgens and the androgen receptor (AR)